(Q33828343)

29 July 2017

title

Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons (English)

1 reference

29 July 2017

David A Wilfret

1

1 reference

29 July 2017

Brent T Baker

2

1 reference

29 July 2017

Elizabeth Palavecino

3

1 reference

29 July 2017

Cassandra Moran

4

1 reference

29 July 2017

Daniel K Benjamin

5

1 reference

29 July 2017

publication date

1 November 2008

1 reference

North Carolina Medical Journal

29 July 2017

published in

1 reference

29 July 2017

volume

69

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

447-452

1 reference

Respiratory syncytial virus: seasonal data for regions of Florida and implications for palivizumab

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Mortality associated with influenza and respiratory syncytial virus in the United States

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Risk of primary infection and reinfection with respiratory syncytial virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Respiratory syncytial virus laboratory surveillance and hospitalization trends in South Texas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Brief report: respiratory syncytial virus activity--United States, 2005-2006.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Substantial variability in community respiratory syncytial virus season timing

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Continuous non-seasonal epidemic of respiratory syncytial virus infection in the southeast United States.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5482212

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19256181

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

5482212

1 reference

29 July 2017

1 reference